# Mycobacterium mageritense-associated refractory cutaneous infection and lymphadenitis in an immunocompetent adult: insights from genomic sequencing

**Authors:** Shinnosuke Fukushima, Jumpei Uchiyama, Yoshio Kawakami, Yoshiko Matsuura, Satoru Sugihara, Shin Morizane, Poowadon Muenraya, Hideharu Hagiya

PMC · DOI: 10.1186/s41182-026-00904-y · 2026-01-16

## TL;DR

A rare Mycobacterium mageritense infection in a healthy adult caused persistent skin and lymph node issues, resolved with targeted antibiotic therapy.

## Contribution

New clinical and genomic insights into M. mageritense infections involving skin and lymph nodes in immunocompetent individuals.

## Key findings

- M. mageritense caused cutaneous infection and lymphadenitis in an immunocompetent adult.
- Genomic analysis identified resistance-related genes and phylogenetic links to Japanese strains.
- Combination therapy with levofloxacin and minocycline resolved the infection after other treatments failed.

## Abstract

Nontuberculous mycobacteria are increasingly recognized as causes of chronic and refractory skin and soft tissue infections, even in individuals without immunodeficiency. Among them, Mycobacterium mageritense is a rare, rapidly growing species that can lead to persistent lesions requiring prolonged antimicrobial therapy. Reports of M. mageritense infections involving both the skin and regional lymph nodes are limited, and this case adds new clinical and genomic insights.

A 48-year-old previously healthy man presented with a slowly enlarging cutaneous lesion on his lower leg and ipsilateral inguinal lymphadenitis. Empirical antibacterial therapy with β-lactams and macrolides was ineffective. Wound cultures subsequently grew M. mageritense, confirmed by whole-genome sequencing. Several antimicrobial regimens were attempted, and the final successful therapy consisted of oral levofloxacin and minocycline for 4 months, leading to complete clinical resolution. Genomic analysis identified resistance-related genes, including erm(40), aac(2′)-Ib, tet(V), and RbpA, although in vitro minimum inhibitory concentrations showed variable susceptibility. Phylogenetic comparison revealed that the isolate was closely related to previously reported M. mageritense strains from Japan.

This case demonstrates that M. mageritense can cause cutaneous infection with secondary lymphadenitis in an immunocompetent host. Accurate species identification using molecular or genomic methods and selection of appropriate combination antibiotic therapy based on susceptibility testing are crucial for successful management of such infections.

## Linked entities

- **Genes:** aac(2')-Ib (aminoglycoside N-acetyltransferase AAC(2')-Ib) [NCBI Gene 93410798], tet(V) (tetracycline efflux MFS transporter Tet(V)) [NCBI Gene 43451962], rbpA (RNA-binding protein RbpD) [NCBI Gene 6481784]
- **Chemicals:** levofloxacin (PubChem CID 149096), minocycline (PubChem CID 54675783)
- **Diseases:** lymphadenitis (MONDO:0002052)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** Cutaneous (MESH:D018366), parakeratosis (MESH:D010241), cutaneous infection (MESH:D007239), swelling lesion (MESH:D011654), skin ulcer (MESH:D012883), subcutaneous (MESH:D013352), RGM (MESH:C538458), inguinal lymphadenitis (MESH:D008199), SSTIs (MESH:D018461), human immunodeficiency virus infection (MESH:D015658), Respiratory infections (MESH:D012141), diabetes mellitus (MESH:D003920), swelling (MESH:D004487), Hyperkeratosis (MESH:D017488), immunological impairment (MESH:D007154), M. mageritense infection (MESH:C566367), trauma (MESH:D014947), Cutaneous mycobacterial infections (MESH:D009165), cutaneous lesion (MESH:D009059), Achilles tendon rupture (MESH:D012421), Antibiotic Resistance (MESH:D004761), skin lesions (MESH:D012871), Inflammation (MESH:D007249), abscesses (MESH:D000038), pulmonary diseases (MESH:D008171), tattoo (MESH:C567128), immunodeficiency (MESH:D007153)
- **Chemicals:** fluoroquinolones (MESH:D024841), beta-lactams (MESH:D047090), quinolone (MESH:D015363), CCL (MESH:D002433), MINO (MESH:D008911), macrolide (MESH:D018942), CAM (MESH:D017291), DRR705878 (-), tosufloxacin (MESH:C055185), aminoglycoside (MESH:D000617), LZD (MESH:D000069349), TMP-SMX (MESH:D015662), tetracycline (MESH:D013752), gentamicin (MESH:D005839), rifampicin (MESH:D012293), cefdinir (MESH:D000077525), SMX (MESH:D013420), TMP (MESH:D013938), steroid (MESH:D013256), tobramycin (MESH:D014031), moxifloxacin (MESH:D000077266), LVFX (MESH:D064704)
- **Species:** Mycolicibacterium mageritense (species) [taxon 53462], Mycolicibacterium fortuitum (species) [taxon 1766], Mycolicibacterium smegmatis (species) [taxon 1772], Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12828916/full.md

---
Source: https://tomesphere.com/paper/PMC12828916